Q3 2025 · 13F-HR
MIC Capital Management UK LLPholdings as filed
Filed 2025-11-14 · accession 0001889830-25-000003
$500.3M
Reported value
13
Positions
2025-09-30
Period end
The Brief · MIC Capital Management UK LLP · Q3 2025
AI · grounded in 13F
MIC Capital Management UK LLP established a new position in HAYW valued at $149.4M. The fund also initiated new stakes in KLAR for $99.5M and RXRX for $47.1M. Additional new positions include CPNG, GRAB, and BABA. The fund ended the period with 13 positions and total AUM of $500.3M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 421298100 | HAYW | HAYWARD HLDGS INC | $149.4M | 29.9% | 9,879,506 | Common | SOLE |
| G5279N105 | KLAR | KLARNA GROUP PLC | $99.5M | 19.9% | 2,714,928 | Common | SOLE |
| 75629V104 | RXRX | RECURSION PHARMACEUTICALS IN | $47.1M | 9.41% | 9,644,032 | Common | SOLE |
| 22266T109 | CPNG | COUPANG INC | $45.5M | 9.09% | 1,412,946 | Common | SOLE |
| G4124C109 | GRAB | GRAB HOLDINGS LIMITED | $30.1M | 6.02% | 5,000,000 | Common | SOLE |
| 01609W102 | BABA | ALIBABA GROUP HLDG LTD | $26.8M | 5.36% | 150,000 | Common | SOLE |
| 76131D103 | QSR | RESTAURANT BRANDS INTL INC | $24.8M | 4.95% | 386,203 | Common | SOLE |
| 30303M102 | META | META PLATFORMS INC | $24.5M | 4.89% | 33,300 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $23.8M | 4.75% | 508,569 | Common | SOLE |
| M7S64H106 | MNDY | MONDAY COM LTD | $12.8M | 2.55% | 66,000 | Common | SOLE |
| 640979100 | NMRA | NEUMORA THERAPEUTICS INC. | $8.1M | 1.62% | 4,460,700 | Common | SOLE |
| 03945R102 | ACHR | ARCHER AVIATION INC | $6.7M | 1.34% | 700,000 | Common | SOLE |
| 55083R203 | LYEL | LYELL IMMUNOPHARMA INC | $1.4M | 0.28% | 87,028 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.